| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.1 |